Public Profile

Bachem Holding AG

Bachem Holding AG, a leading global player in the biotechnology sector, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1971, Bachem has established itself as a pioneer in the development and production of peptide-based active pharmaceutical ingredients (APIs) and innovative drug delivery systems. The company’s core offerings include high-quality peptides and complex organic molecules, which are distinguished by their exceptional purity and reliability. Bachem's commitment to quality and sustainability has earned it a prominent position in the pharmaceutical and biotech industries, with notable achievements in custom synthesis and contract manufacturing. As a trusted partner for major pharmaceutical companies, Bachem continues to drive advancements in therapeutic solutions, solidifying its reputation as a leader in peptide chemistry.

DitchCarbon Score

How does Bachem Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Bachem Holding AG's score of 30 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Bachem Holding AG's reported carbon emissions

Bachem Holding AG, headquartered in Switzerland, currently does not have publicly available carbon emissions data for the most recent year. However, the company is committed to addressing climate change through various initiatives. Bachem has made a near-term commitment to reduce its carbon footprint, although specific reduction targets or timelines have not been disclosed. As a player in the Pharmaceuticals, Biotechnology, and Life Sciences sector, Bachem is aware of the industry's impact on the environment and is taking steps to align with sustainability goals. While the company has not committed to a net-zero target, it is actively engaged in climate action, indicating a proactive approach to managing its environmental responsibilities. Bachem's commitment to reducing emissions reflects a growing trend within the industry to enhance sustainability practices and mitigate climate impact. The company’s ongoing efforts will be crucial in contributing to broader climate goals and improving its environmental performance in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bachem Holding AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bachem Holding AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Bachem Holding AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

AmbioPharm, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Glenmark Life Sciences

IN
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Corden Pharma GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers